HHS Announces New Funding Opportunities for AI Behavioral Health Projects

Define the problems the organization is willing to fund before reviewing technologies or opportunities. Examples include unsafe transitions between physical and behavioral health care, incomplete crisis follow-up, administrative burden, inconsistent risk identification, fragmented consent, poor data quality, and lack of timely outcomes. Tie each problem to strategic priorities, affected populations, an accountable executive, and a measurable baseline.

Create investment principles. A project should improve a defined clinical or operating decision, fit the care model, use data lawfully, preserve meaningful human oversight, support interoperability, and have a credible route to sustained ownership. Require evidence proportional to risk. An administrative prototype may justify a lighter test than a tool influencing diagnosis, treatment, suicide-risk response, or access to care.

Organize the portfolio by capability and maturity rather than by vendor. Distinguish foundational data work, research, prototype, validation, limited deployment, and scaled operations. Map dependencies such as identity matching, terminology, FHIR interfaces, consent management, cybersecurity, model monitoring, workflow redesign, and staff capability. This reveals when a visible AI project is moving ahead of less visible infrastructure.

Set explicit exclusions and pause conditions. Do not fund a use case if the organization cannot define the user, intended action, data provenance, oversight, failure response, or affected population. A disciplined pause protects capital and creates leverage to repair the foundation.

Translate the thesis into an annual allocation range. Reserve distinct capacity for foundational infrastructure, evidence generation, workflow implementation, and evaluation so attractive demonstrations do not consume every dollar. Require tradeoff decisions when a new proposal enters the portfolio. An explicit allocation makes the opportunity cost visible and helps the board distinguish strategic investment from an expanding collection of experiments.

Build a capital stack for each initiative. Identify what a grant can legitimately fund, what internal capital must cover, what belongs in the operating budget, and whether philanthropy, research support, payers, or partners can contribute without compromising governance. Avoid assuming that a future award will pay for core staffing or infrastructure already necessary for safe operations.

Calculate total cost through sustainment. Include integration, cybersecurity, data stewardship, privacy review, clinical leadership, training, workflow redesign, patient engagement, evaluation, vendor management, monitoring, support, upgrades, and retirement. A free or grant-funded license can be a small share of the true cost. Finance should show multi-year scenarios and the trigger for a stop, renew, replace, or scale decision.

Structure partner agreements around outcomes and control. Define data rights, model or tool changes, validation access, performance reporting, subcontractors, cybersecurity, breach response, intellectual property, publication, termination assistance, and data return or destruction. Disclose financial interests and guard against a partner using the pilot as an uncontrolled route to patient data or product endorsement.

Reserve transition funding for successful pilots. If every dollar is consumed by initial development, the organization may be unable to integrate, train, monitor, or scale the result. A stage-gated reserve tied to evidence creates a practical bridge from project to operation.